ALL a b c d e f g h i j k l m n o p q r s t u v w x y z #

Webinars starting with P

Provider Affiliations Using Graph Networks: A New Approach to an Old Problem

Provider Affiliations Using Graph Networks: A New Approach to an Old Problem
Monday, 02 May 2022

Provider affiliations, between practitioners and facilities and facilities and IDNs, have been a foundational element of pharma analytics. Yet, building accurate provider affiliations is hard. One reason is scale. With millions of links across HCPs (healthcare professionals) and healthcare organizations (HCOs), manual or survey-based methods are limiting.

In this webinar, Compile, Inc. will describe a novel approach to constructing affiliations. Using a combination of graph networks and data triangulation, the drawbacks of individual data sources are mitigated. Further, participants will learn how graph structures are well suited in capturing the complex hierarchy that characterizes health systems today. Finally, the webinar will explain how this new affiliation structure, with quantitatively scored links, can help in common pharma use cases from sales attribution to account-based targeting. The webinar will be targeted toward data and analytics savvy audience.

Patient Data Applications Across Product Lifecycle

Patient Data Applications Across Product Lifecycle
Wednesday, 11 November 2020

Anonymized Patient Level Data (APLD) has been gaining popularity in recent times in commercial analytics. Since it provides rich longitudinal patient history, it is routinely used to understand patient journey, payor dynamics, and define HCP targeting strategies.

However, this is only scratching the surface when it comes to realizing the full potential of the data asset. Patient Claims Data has many applications across various stages of the product lifecycle, right from pre-clinical stage to loss of exclusivity.

This data can be used to guide strategic decisions such as acquisition of pre-clinical assets and can aid in identifying geographic concentration of patients of interest for enrollment into clinical trials.

Anonymized Patient Data also offers what traditional HCP level Rx data is unable to offer – estimating the “Potential Opportunity” for your product among different providers. Machine Learning models that predict volume of patients in different stages of a disease across different time intervals are useful in targeting HCPs that have the larger volume of specific types of patients of interest. This enables precise targeting of HCPs for sales and marketing efforts, as well as customization of messaging based on prescription and referral patterns, particularly at launch.

When combined with call and promotional activity data, it can be used to measure campaign and message effectiveness, responsiveness to new communication channels, and to design near real-time tactics to gain and maintain market share. This is particularly critical in today’s times when sales reps are unable to meet with physicians in person due to the COVID-19 pandemic.

SRI has unique expertise in leveraging Anonymized Patient Data across all stages of the drug life cycle.

Speakers:/p>

  • Sudhakar Mandapati, Principal, Strategic Research Insights, Inc.
  • Harshad Chiddarwar, Director, Strategic Research Insights, Inc.
  • Ren Zhao, Sr. Engagement Manager, Strategic Research Insights, Inc.
  • Gina Nelson, Senior Director, New Product Planning, Gossamer Bio, Inc.

Power of Analytics to Optimize Promotional Investments As We Stabilize and Move Towards Reopening

Power of Analytics to Optimize Promotional Investments As We Stabilize and Move Towards Reopening
Wednesday, 12 August 2020

When an unforeseen pandemic like COVID-19 causes catastrophic disruption to the global healthcare system, we can look at more innovative analytical approaches and technology to help guide brand’s planning and forecasting.

As the country reopens at different paces regionally, analyzing promotional mix in real time and against historical activities will be critical.

This webinar will share how to optimize promotional investments in this dynamic market using data to inform and predict factors that will impact brand sales. This includes identifying the optimal time, channel, and sequence at the brand, portfolio and regional level.

In this webinar, we will explore the impact of the pandemic on promotional execution strategy, focusing on success stories of how organizations are pivoting with agility to meet the challenges of the COVID-impacted environment; specifically, the following areas:

  • Optimizing promotional investment to account for loss /reduced personal promotions and its impact on brand forecast
  • Customizing channel sequence at segment and/or individual customer level

Presenters:

  • Paulomi Patel, Principal, Analytical Wizards
  • Mike Steward, Principal and Chief Digital Officer, Analytical Wizards